Clinical Study to Evaluate the Safety and Efficacy of the Vela100

Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.

Circumference Reduction Clinical Trial

Official title:
Clinical Study to Evaluate the Safety and Efficacy of the Vela100/eShape Uno Device for Cellulite and Circumference Reduction

Status Terminated

Clinical Trial Summary

This study is intended to test the safety of the Vela100 device when used for treatment for cellulite and circumference temporary reduction.

n/a

Endpoint Classification: Safety Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment

See also
Status	Clinical Trial	Phase
Completed	`NCT02109107` - Study of Low Level Laser Light Therapy on Circumference Reduction	N/A
Completed	`NCT05674292` - An Evaluation of the Effect of the Erchonia Corporation Violet Zerona® Z6 for Body Contouring	N/A
Recruiting	`NCT02956720` - UltraShape Power in Combination With U-sculpt-n Transducer	N/A
Terminated	`NCT02591056` - Study of the Combined Effect of Low Level Laser Therapy and Manual Lymph Drainage on Reducing Body Circumference	N/A
Completed	`NCT03430245` - VelaShape III & UltraShape Power for Thigh Circumference Reduction	N/A
Completed	`NCT01234259` - Evaluation of Safety and Efficacy of Using Venus Freeze™ (MP)2 V2 System for Wrinkles Rhytides and Cellulite Treatment	N/A